Europe's medical agency eyes safety of two COVID-19 vaccines
In a statement the EU medicines regulator said it had already begun a ``rolling review'' of the vaccine based on laboratory data previously submitted by Moderna and would now assess data on how well the vaccine triggers an immune response.